Tag: KELIX Bio
Mubadala’s KELIX bio completes acquisition of DiabTec
KELIX bio, wholly owned by Mubadala Investment Company, an Abu Dhabi sovereign investor, has completed the acquisition of DiabTec, a subsidiary of Julphar.
This acquisition...
Mubadala’s KELIX bio to acquire 4 GlobalOne Healthcare Holding assets
Mubadala Investment Company, an Abu Dhabi sovereign investor, has empowered its new specialty pharmaceutical business, KELIX bio, to acquire a 100 percent stake in...
Mubadala acquires KELIX bio to develop UAE’s life science ecosystem
Mubadala Investment Company PJSC (Mubadala), an Abu Dhabi sovereign investor, has entered into a definitive agreement to acquire KELIX bio, a specialty pharmaceutical business...
Dubai-based KELIX bio to acquire Moroccan Pharma company PHI
Dubai-based KELIX bio, a unique pan-African biopharmaceutical platform, has entered into a binding commitment to acquire Pharmaceutical Institute (PHI), a leading pharmaceutical company established...
